Treats schizophrenia. ANDA 206433, held by Aurobindo Pharma. Clozapine.
As of Nov 15, 2026, ANDA 206433 (Clozapine), held by Aurobindo Pharma, was first approved by FDA on Nov 29, 2016, with 14 approved supplements and 0 published complete response letters.
Clozapine tablets are an atypical antipsychotic indicated for: Treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Because of the risks of severe neutropenia and of seizure associated with its use, clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior. 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 29, 2016 | Original application | Approved |
| Sep 29, 2026 | Supplement 26Labeling · Standard review | Approved | None posted |
| Sep 29, 2026 | Supplement 21Labeling · Standard review | Approved | None posted |
| Sep 29, 2026 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jun 13, 2025 | Supplement 22REMS | Approved | None posted |
| Aug 14, 2023 | Supplement 19Labeling · Standard review | Approved | None posted |
| Aug 14, 2023 | Supplement 17Labeling · Standard review | Approved | None posted |
| Aug 14, 2023 | Supplement 10Labeling · Standard review | Approved | None posted |
| Aug 14, 2023 | Supplement 8Labeling · Standard review | Approved | None posted |
| Nov 10, 2021 | Supplement 13REMS | Approved | None posted |
| Jul 29, 2021 | Supplement 12REMS | Approved | None posted |
| Feb 18, 2021 | Supplement 9REMS | Approved | None posted |
| Jan 16, 2019 | Supplement 4REMS | Approved | None posted |
| Apr 25, 2017 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 25, 2017 | Supplement 1Labeling · Standard review | Approved | None posted |
| Nov 29, 2016 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters